AFM
REVB icon

Anson Funds Management’s Revelation Biosciences REVB Stock Holding History

Anson Funds Management’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-37
Closed -$278K – 195
2023
Q1 		$278K Buy
+37
New +$999K 0.07% 148
2022
Q1 		– Hold
0
– -$510K – 427
2021
Q4 		– Hold
0
– – – 226
2021
Q3 		– Hold
0
– – – 248

Other funds holding REVB

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return